In a variety of PAD4-overexpressing cancer cells, treatment with PAD4 inhibitors or PADI4 short interfering RNA (siRNA) increased the expression of p53 target genes, leading to cell cycle arrest and apoptosis [15,16]. This evidence concerns the gene TP53 and cancer.